Direxion Daily Pharmaceutical & Medical Bull 3X ETF
PILL
5 hedge funds and large institutions have $2.52M invested in Direxion Daily Pharmaceutical & Medical Bull 3X ETF in 2022 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 2 closing their positions.
0.41% more ownership
Funds ownership: 12% → 12.41% (+0.41%)
0% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 2
17% less funds holding
Funds holding: 6 → 5 (-1)
40% less capital invested
Capital invested by funds: $4.17M → $2.52M (-$1.66M)
50% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
OMC
Old Mission Capital
Chicago,
Illinois
|
+$692K |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
+$241K |
| 3 |
Simplex Trading
Chicago,
Illinois
|
+$2.69K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACMA
Arbor Capital Management (Alaska)
Anchorage,
Alaska
|
-$1.16M |
| 2 |
Goldman Sachs
New York
|
-$737K |
| 3 |
Jane Street
New York
|
-$425K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$58.4K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
OMC
1
Old Mission Capital
Chicago,
Illinois
| $1.04M | +$692K | +51,429 | +253% |
|
|
TRCT
2
Tower Research Capital (TRC)
New York
| $675K | +$241K | +17,881 | +62% |
|
|
3
Goldman Sachs
New York
| $576K | -$737K | -54,760 | -58% |
|
|
4
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $223K | -$58.4K | -4,339 | -22% |
|
|
5
Simplex Trading
Chicago,
Illinois
| $2K | +$2.69K | +200 | New |
|
|
ACMA
6
Arbor Capital Management (Alaska)
Anchorage,
Alaska
| – | -$1.16M | -61,842 | Closed |
|
|
7
Jane Street
New York
| – | -$425K | -26,747 | Closed |
|
PILL Hedge Fund Activity: Q1 2022 in Review
5 of the 6,341 institutional investors tracked by Wall St. Rank reported a position in Direxion Daily Pharmaceutical & Medical Bull 3X ETF (PILL) for Q1 2022, worth a combined $2.52M — down 40% from $4.17M a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of PILL and 1 opened new positions — a net loss of 1 holder — while 2 trimmed existing stakes and 2 added.
The largest buyer was Old Mission Capital, adding an estimated $692K. The largest seller was Arbor Capital Management (Alaska), exiting entirely with an estimated $1.16M sold.
- 5 institutional investors held Direxion Daily Pharmaceutical & Medical Bull 3X ETF (PILL) as of Q1 2022, down from 6 in Q4 2021.
- Funds reported $2.52M of Direxion Daily Pharmaceutical & Medical Bull 3X ETF stock for Q1 2022, down 40% quarter-over-quarter.
- 1 fund opened new Direxion Daily Pharmaceutical & Medical Bull 3X ETF positions in Q1 2022 and 2 closed out, a net change of -1 holder.
- The largest Direxion Daily Pharmaceutical & Medical Bull 3X ETF buyer in Q1 2022 was Old Mission Capital, an estimated $692K added.
- The largest Direxion Daily Pharmaceutical & Medical Bull 3X ETF seller in Q1 2022 was Arbor Capital Management (Alaska), an estimated $1.16M sold.
Based on aggregated 13F filings for Q1 2022.